Though patients on antiretroviral therapy were not stated to be included, a Japanese case-control study indicated that CYP3A4 (13989A>G) polymorphism is associated with the prevalence of type 2 diabetes mellitus [31]. This evidence concerns the gene CYP3A4 and type 2 diabetes mellitus.